48 related articles for article (PubMed ID: 2646895)
1. Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease.
Yamashita S; Masuda D; Ohama T; Arai H; Bujo H; Kagimura T; Kita T; Matsuzaki M; Saito Y; Fukushima M; Matsuzawa Y;
J Atheroscler Thromb; 2016 Jun; 23(6):746-56. PubMed ID: 26803913
[TBL] [Abstract][Full Text] [Related]
2. [Impact of dietotherapy with enterosorbent of marine origin on the indices of mineral and lipid metabolism for patients suffering from kidney diseases].
Rudichenko EV; Gvozdenko TA; Antoniuk MV
Vopr Pitan; 2005; 74(4):33-5. PubMed ID: 16265914
[TBL] [Abstract][Full Text] [Related]
3. The Role of Necroptosis in ROS-Mediated Cancer Therapies and Its Promising Applications.
Hsu SK; Chang WT; Lin IL; Chen YF; Padalwar NB; Cheng KC; Teng YN; Wang CH; Chiu CC
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32764483
[TBL] [Abstract][Full Text] [Related]
4. A randomized, open-label, multicentre study to evaluate plasma atherosclerotic biomarkers in patients with type 2 diabetes mellitus and arteriosclerosis obliterans when treated with Probucol and Cilostazol.
Ma XW; Guo XH; Xiao XH; Guo LX; Lv XF; Li QM; Gao Y
J Geriatr Cardiol; 2012 Sep; 9(3):228-36. PubMed ID: 23097651
[TBL] [Abstract][Full Text] [Related]
5. Effects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefit.
McTaggart F; Jones P
Cardiovasc Drugs Ther; 2008 Aug; 22(4):321-38. PubMed ID: 18553127
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin: a pharmacoeconomic evaluation of its cost-effectiveness in hypercholesterolaemia and prevention of coronary heart disease.
Chrisp P; Lewis NJ; Milne RJ
Pharmacoeconomics; 1992 Feb; 1(2):124-45. PubMed ID: 10146941
[TBL] [Abstract][Full Text] [Related]
7. The effects of simvastatin and pravastatin on objective and subjective measures of nocturnal sleep: a comparison of two structurally different HMG CoA reductase inhibitors in patients with primary moderate hypercholesterolaemia.
Eckernäs SA; Roos BE; Kvidal P; Eriksson LO; Block GA; Neafus RP; Haigh JR
Br J Clin Pharmacol; 1993 Mar; 35(3):284-9. PubMed ID: 8471404
[TBL] [Abstract][Full Text] [Related]
8. Effects of therapy with diet and simvastatin on atherosclerosis in hypercholesterolemic patients.
Barlow CW; Friedman BM; Myburgh DP; Soicher ER; Steenkamp WF; Smith DH
Cardiovasc Drugs Ther; 1990 Oct; 4(5):1389-94. PubMed ID: 2278874
[TBL] [Abstract][Full Text] [Related]
9. Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition on human gut mucosa.
Gebhard RL; Ewing SL; Schlasner LA; Hunninghake DB; Prigge WF
Lipids; 1991 Jul; 26(7):492-4. PubMed ID: 1943491
[TBL] [Abstract][Full Text] [Related]
10. Metabolic fate of 2,2-dimethylbutyryl moiety of simvastatin in rats: identification of metabolites by gas chromatography/mass spectrometry.
Uchiyama N; Kagami Y; Saito Y; Abe S; Ohtawa M; Hata S
Eur J Drug Metab Pharmacokinet; 1991; 16(3):189-96. PubMed ID: 1814736
[TBL] [Abstract][Full Text] [Related]
11. HMG-CoA reductase inhibitor use in the aged. A review of clinical experience.
Lintott CJ; Scott RS
Drugs Aging; 1992; 2(6):518-29. PubMed ID: 1493355
[TBL] [Abstract][Full Text] [Related]
12. A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia. The Lovastatin Study Group IV.
Am J Cardiol; 1990 Sep; 66(8):22B-30B. PubMed ID: 2206033
[TBL] [Abstract][Full Text] [Related]
13. [Swiss simvastatin multicenter study: 1. Efficacy of 10 mg simvastatin daily in patients with primary hypercholesterolemia].
Riesen WF; Keller U; Del Bufalo A; Reutter FW; Baur HR; Golay A; Bertel O; Kummer H; Kistler H; Ammann F
Schweiz Med Wochenschr; 1989 Dec; 119(48):1719-23. PubMed ID: 2694363
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia.
Plosker GL; McTavish D
Drugs; 1995 Aug; 50(2):334-63. PubMed ID: 8521762
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of simvastatin and lovastatin in patients with hypercholesterolemia. The Simvastatin and Lovastatin Multicenter Study Participants.
Farmer JA; Washington LC; Jones PH; Shapiro DR; Gotto AM; Mantell G
Clin Ther; 1992; 14(5):708-17. PubMed ID: 1468089
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia.
Todd PA; Goa KL
Drugs; 1990 Oct; 40(4):583-607. PubMed ID: 2083515
[TBL] [Abstract][Full Text] [Related]
17. Effects of simvastatin and probucol in hypercholesterolemia (Simvastatin Multicenter Study Group II).
Pietro DA; Alexander S; Mantell G; Staggers JE; Cook TJ
Am J Cardiol; 1989 Mar; 63(11):682-6. PubMed ID: 2646895
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
